WOOJUNG BIO Inc (215380) — Cash Flow Quality Index

Latest as of December 2024: -5.00x

WOOJUNG BIO Inc (215380) has a Cash Flow Quality Index of -5.00x as of December 2024. Operating cash flow of ₩-1.13 Billion is below net income of ₩225.30 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 215380 cash flow metrics to assess how effectively this company generates cash.

Cash Flow Quality Index

-5.00x
Operating CF / Net Income

Operating Cash Flow

₩-1.13 Billion
KRW

Net Income

₩225.30 Million
KRW

Data as of

Dec 2024
Most recent filing

WOOJUNG BIO Inc Cash Flow Quality Index (2015–2024)

Historical Cash Flow Quality Index for WOOJUNG BIO Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of WOOJUNG BIO Inc to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for WOOJUNG BIO Inc (2015–2024)

Year-by-year earnings quality comparison for WOOJUNG BIO Inc. For live market cap and the full company financial profile, see 215380 company net worth.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2024 -5.00x ₩-1.13 Billion ₩225.30 Million ▼ -769.7%
2019 0.75x ₩208.72 Million ₩279.59 Million ▲ +104.0%
2016 -18.84x ₩-1.46 Billion ₩77.25 Million ▼ -9440.7%
2015 -0.20x ₩-11.39 Million ₩57.67 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.